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the software were compared to the treatment plan and to calibrated EBT3 film, using the 2D gamma analysis method.
Results: For the original plan, the "magic phantom" system was capable of measuring all dwell points and dwell times and the majority were found to be within 0.93 mm and 0.25 s, respectively, from the plan. By measuring the altered plan and comparing it to the unmodified treatment plan, the use of the position-time gamma index showed that all modifications made could be readily detected. The MPh was able to measure dwell times down to 0.067 ± 0.001 s and planned dwell positions separated by 1 mm. The dose calculation carried out by the MPh software was found to be in agreement with values calculated by the treatment planning system within 0.75%. Using the 2D gamma index, the dose map of the MPh plane and measured EBT3 were found to have a pass rate of over 95% when compared to the original plan.
Conclusions: Our application of the "magic phantom" quality assurance system to HDR brachytherapy has demonstrated promising ability to perform the verification of treatment plans, based upon the measured dwell positions and times. The introduction of the quantitative position-time gamma index allows for direct comparison of measured parameters against the plan, and could be used prior to patient treatment to ensure accurate delivery.
Introduction
Due to the severe consequences associated with the incorrect delivery of High Dose Rate (HDR) brachytherapy treatments, it is essential that the measurement of source dwell times and verification of dwell location can be undertaken with high precision. Human and calculation errors introduced during the treatment planning and preparation processes, in addition to incorrect calibration of the HDR afterloader, can potentially lead to incorrect dwell location and timing during treatment, resulting in the misadministration of dose to the treatment volume 1,2,3 .
Brachytherapy treatment planning systems (TPS) employ algorithms based on the AAPM TG-43U1 protocol 4 to calculate dose distributions around the HDR source, and to plan the necessary treatment.
Since the treatment relies on the correct delivery of the plan by the HDR remote afterloader, it is desirable to develop an independent quality assurance (QA) method that accurately verifies the HDR source dwell positioning and timing pattern for each catheter. A sound QA program should include a pre-treatment plan verification 5 and would give confidence of a correct execution at the time of treatment. Although the afterloader has high precision in its control of the source movement, treatment outcomes of plans with multiple catheters are more susceptible to deviations in dwell position and time 6 .
There have been efforts found within the literature to develop a method for verification of planned dwelling and timing patterns before and during treatment. These include pinhole imaging 7, 8 , diamond detectors 9 , flat panel 10 and EPIDs 11 , film and photodiodes 12 , ion chamber arrays 13 and video cameras * .
These devices, while capable of source tracking, can be costly and are limited in their ability to perform a quick, comprehensive and automated analysis of a full treatment plan.
The feasibility study of a two dimensional detector array "magic plate", housed inside a "magic phantom" (MPh), showed the "magic plate" to be capable of determining the source position within three dimensions with a fast acquisition speed (0.1 -100 ms) 14 . This work seeks to evaluate the proof of concept performance of the novel MPh, with updated electronics and software toolkit, as a complete system for HDR pre-treatment plan and afterloader verification. We aim to show that the MPh has the potential to accurately measure the dwell positions and times of any treatment, compare those measured values against the treatment plan, determine any errors in delivery, and estimate the total dose delivered -including the transit dose contribution along the "magic plate" plane.
The MPh system was CT scanned and using ONCENTRA® TPS (Nucletron, the Netherlands), two 20 catheter treatment plans were created. The treatment plans were measured using the MPh and the dwell positioning and timing were evaluated based on a new acceptance criterion for HDR QA, A copy of the plan was created and modified by a member of the hospital medical physics staff, without the supervision of the authors, and an undisclosed number of changes were made. The plan was altered by the inclusion of new dwell points, points shifted or removed, and dwell times lengthened or shortened, to simulate a scenario where there is a misadministration by the afterloader.
Each plan was exported as a DICOM file, preserving the source dwell and timing information for each catheter and the calculated absorbed dose at each detector position on the MP. Both DICOM plan files were subsequently read by the custom software suite; first to compare the measured dwelling position-time pattern with the original plan and identify the modifications using the position-time gamma analysis, and then to verify that all alterations measured were indeed made within the modified plan. All plans were delivered using the Flexitron HDR afterloader (Nucletron, the Netherlands) at the St George Cancer Care Centre, Sydney.
Methods

3.A. Determination of source dwell positions and dwell times
A method for determining the HDR 192 Ir source position using a two dimensional detector array was introduced within the "magic plate" feasibility study
14
. It is based on the sampled dose rate measurements from the nine neighboring diodes with the largest signals, followed by an iterative optimization procedure that takes into account the angular response of the diodes 27 . This method calculates, for each frame of measurement, the x-y-z coordinates of the HDR source when in the FOV of the MPh detectors. Building upon these results, the software interface was designed to automatically determine the source dwell positions and dwell times from the treatment measurement.
Time gaps between the last position of each catheter and the first dwell of the next catheter do not affect the source position determination, as there is extremely little signal when the source is outside of the phantom. When the maximum signal during a measurement frame is below a predetermined threshold level, the software does not execute the source position calculation algorithm. The threshold level is dependent on the expected range of source activity and corresponds to the estimated current generated within a detector by a source at a distance of 150 mm away in the z direction, inside the FOV of the MPh. The noise level is very low in this developed system, and consequently, has minimal bearing on measurements.
The unmodified 20 catheter plan delivery was measured using the MPh and the source position was 
3.B. Determination of the minimum measurable step size and dwell time
The Flexitron HDR afterloader can be programmed to drive the HDR source using varying step sizes and dwell times, with a minimum of 1 mm and 0.1 s, respectively. To be feasible for plan verification, the MPh system must be able to determine dwell positions and times accurately, over this range of step sizes and dwell times.
To assess the dwell position resolution of the system, the afterloader was programmed to deliver the HDR source through a single catheter, moving with progressively reduced step sizes down to 1 mm.
Each dwell position had a programmed dwell time of 3 s and was measured using the MPh system.
The transit time of the source from one dwell position to the next was also measured.
To assess the dwell time resolution of the system, the HDR afterloader was programmed to drive the source to 3 dwell positions within a single catheter for the same amount of time. The measurement was repeated for a range of dwell times from 10 s down to 0.1 s.
3.C. Position-time gamma index
To quantitatively compare the source position and dwell times within the catheter to the treatment plan, a new metric is introduced based upon the dose-position gamma index. The use of the 2D gamma index in QA was first described by Low et al 15 and was used to quantitatively compare dose distributions for external beam radiation therapy. It compares the dose difference, point-by-point, and the distance-to-agreement between the evaluated dose distribution and that of the reference dose distribution, and is used for analysis in sections 3.E and 4.E.
Adopting the formalization of this method and applying it to HDR brachytherapy, it is possible to compare the measured treatment to the plan by evaluating the source dwell and timing patterns. By using acceptable distance-to-agreement and time-to-agreement criteria values, a pass-fail grade (pass if gamma value is equal to or less than 1) is determined for all measured dwell positions and times. ONCENTRA® TPS was used to calculate the necessary time to deliver a dose to the center of the film, with the 5 pieces of film irradiated to 100, 200, 400, 600 and 1000 cGy using a single dwell position.
All pieces of film were pre-scanned and post-irradiation scanned using a 48-bit RGB transmission film scanner, the EPSON 10000XL, at a resolution of 300 dpi, with no color or sharpness corrections and at a consistent orientation and position to the scanner. Approximately 72 hours passed between film irradiation and scanning to ensure the film response had stabilized. The calibration films were scanned and the image files were measured using IMAGEJ (version 1.47v). Six consecutive scans were performed for each piece of film to ensure consistent performance of the scanner on the last three used for analysis. A calibration curve was generated for the red color channel based upon the largest change in optical density and exposed dose. The total uncertainty was calculated to be approximately 6.1% (1 S.D), based upon an uncertainty budget which considers the source-to-film position, scanner inhomogeneity and reproducibility and the TPS dose calculations and source activity measurements.
Using the software, dose maps were generated along the MPh detector plane for the original treatment plan, the measured treatment based upon the measured dwell positions and times, and for the modified treatment plan. The original treatment plan was then measured by replacing the "magic plate" detector with EBT3 film. The film was cut to match the size of the "magic plate" and markings were made for alignment. Both the film and "magic plate" were later scanned using the scanner, so that the film dose map positions could be registered to those calculated by the MPh software. The change in optical density was converted to dose using the calibration curve. The dose maps were then compared using the 2D gamma analysis, with varying dose difference and distance-to-agreements criteria. Each map had a size of 10x10 cm
The total transit dose for the MPh diode positions was also estimated by performing dose calculations for each measured source position between dwell positions, assuming a discrete source movement between consecutive frames. Figure 4 shows the calculated source position and dwell time in a position within the first catheter verses time, determined by the algorithm described in detail in previous study 14 . It can be seen that the source travels from the afterloader and dwells at the furthest dwell position away from the catheter tip, A position frequency histogram was generated from the source tracking calculations for each catheter.
Results
4.A. Determination of source dwell positions and dwell times
Each histogram had a bin width of 0.1 mm and the counts of source position were related to the electronic sampling frequency. Each count within the histogram represented 1 ms of time that the source had spent at that calculated position. Figure 5 shows the histogram for Catheter 1. Each dwell point was seen to be a narrow peak, where the center was equal to the dwell position and the FWHM was the uncertainty of position. The number of counts converted to time under each peak is equal to the total dwell time for that dwell position.
The calculated and TPS planned dwell position-time patterns for catheter 1 are also presented in Figure 6 . Uncertainties in the dwell positions were typically of the order of 0.2 mm (2 S.D) and are unable to be seen on this graph. Good agreement between these dwell patterns were seen for the majority of points, except for those close to 0 mm, due to the edge of FOV effect. The dwell positions and times were compared to the treatment plan. The average difference between the measured dwell position and the TPS plan for 86 dwell positions was 0 ± 0.63 mm (2 S.D), taking into account the larger differences due to the edge of FOV effect.
Seen in Figure 8 , the dwell time differences were found to be less than 0.25 s, and the majority showed that the MPh measured less than the expected planned dwell times. It is expected that due to the highly accurate internal clock of the electronics used, the error in timing is extremely small.
This difference in dwell time is most likely due to a feature of the Flexitron afterloader that reduces dwell times to compensate for additional dose delivered while the source is in transit between successive dwell points. In Figure 9 , the differences in dwell times are plotted against the interdwell distances (the distance between two dwell positions), showing that the difference in dwell time for the subsequent position is proportional to the distance the source had to travel. An interdwell distance of 0 mm represents the first dwell position within the catheter, where it is expected that there will be no change in dwell time.
According to the ONCENTRA® MasterPlan Physics and Algorithms manual ‡ , it is assumed that this afterloader drives the source at a speed of 50 cm/s and for an interdwell distance of 50 mm the dwell time is reduced by a maximum of 0.1 s. It is noted that this feature may not be seen in some afterloaders. The measured dwell time differences are larger than expected but, as seen in the feasibility study for the "magic plate" detector, the average source speed was measured and found to vary from 12.5 to 37.5 cm/s based on interdwell distance 14 . Although a different afterloader was used for the feasibility study, if it is assumed they share similar average source speeds, the variation in dwell time difference can be justified.
4.B. Determination of the minimum measurable interdwell distance and dwell time
The HDR source was driven to 9 dwell positions in a single catheter, with spaces between dwell positions varying from 30 mm to 1 mm. As seen in Table 2 , the dwell positions were determined by the MPh, and the system was capable of resolving the dwell positions separated by 1 mm. There is some deviation noted between dwell positions, which may be due to the edge of FOV effect ‡ Oncentra MasterPlan v3.2, Physics and Algorithms Manual, 192.739ENG-02, Nucletron, the Netherlands.
previously discussed. The dwell times for each position were found to follow the trend of reduced times, as a function of interdwell distance ( Figure 9 ) and agreed with the determined transit times. The minimum measurable dwell time for the MPh system was evaluated by using three dwell positions, at 13.6 mm, 18.6 and 28.6 mm from the catheter tip, and varying the planned times. Each position was set to have the same dwell time, but these varied when measured, except for Position 1 which was the first the source was driven to. In Table 3 , it can be observed that the minimum dwell time that was measured was 0.067 ± 0.001 s (2.SD). Following the trend of dwell time reduction, for the planned dwell times of 0.1 s, Position 2 was expected to have a time of 0.01-0.02 s, but could not be detected by the system due to not being distinguishable within the position frequency histogram. The verification of the accuracy of all dwell times set by the TPS is impossible, as the afterloader always modifies the actual dwelling time by taking the transit time into account. We have, however, demonstrated an obvious relationship between the absolute dwell time and interdwell distance, which is noticeable for all dwell times. This shows that the timing capabilities of this developed system surpass the programmable limitations of the afterloader system.
4.C. Position-time gamma analysis
The software suite determines the dwell position and times for all the catheters and compares them against the treatment plan using the position-time gamma analysis. By applying the equations described in Table 1 Applying the gamma index to all 20 catheters, it can be seen from Figure 11 that the majority of the treatment (95%) have gamma values of less than or equal to 1. There are 5 points with gamma values greater than 1, but they are considered to pass, due to their uncertainty.
4.D. Position-time gamma index on modified plan
The modified plan was measured using the MPh and using the results from the position-time gamma analysis, an estimated 11 changes were expected to have been made to the treatment plan. One change to Catheter 3, seen in Figure 12 , was the addition of a dwell position. This position was seen to be at 17.2 ± 0.1 mm (2 S.D) from the coordinate origin, with a dwell time of 14 s. 
4.E. Comparisons between "magic phantom" calculated dose, TPS and EBT3 film dose measurements
The TPS DICOM file of the original plan was read by the MPh software, and the coordinates and value of each dose calculation were acquired. The software subsequently recalculated the dose at the same points using its own implementation of the TG-43U1 protocol, using the same planned parameters. Good agreement was found between the MPh software estimated doses for the 121 positions and the TPS, with values within ± 0.75% (2 S.D) suggesting that the dose calculation engine based on predetermined dwell positions and times is correct.
Two-dimensional 10x10 cm 2 dose maps along the MPh plane were generated using the TG-43U1
calculation tool with 0.5x0.5 mm 2 pixel size. These were produced for the planned and measured source dwell positions and times of the original plan, and for the measured modified plan. The calculated 2D dose map for the measured dwell positions and times of the original plan is shown in Figure 15 . The film was irradiated using the unmodified plan and processed to create a map with the same dimensions and resolution as the others. The MPh system was also capable of estimating the contribution of the total transit dose for this plan by calculating the dose delivered for the sampled transit positions only. Seen in Figure 16 , the total maximum transit dose was calculated to be 18 cGy for the measured plan. This represents an average of 4.8 ± 2.3% (2 S.D) increase in dose delivered when compared to the total dose delivered from the dwell positions only. This result is dependent on the source activity and for this particular plan the transit dose contribution could double when delivered directly after a source exchange, assuming the same transit times.
All dose distributions were compared using the 2D gamma analysis for varying dose difference and distance-to-agreement criteria, and the results are shown in Table 4 . The dose difference value was calculated based upon the maximum dose within the compared maps. It is evident that by using a dose difference of 4% and distance-to-agreement of 3 mm, a pass rate of over 95% could be achieved for both the MPh dose map without the transit dose and the film for the original plan. When considering the transit dose contribution, a pass rate of over 90% for all criteria examined was obtained. This suggests that the reduction of the dwell times is an appropriate method to compensate for the total transit dose when executing this plan. Using lower criteria values reduced the pass rate for film, most likely due to the registration of the film position to the MPh and the associated uncertainty in the film dose calculation. The modified plan gave a pass rate of 49.3% for the dose difference of 4% and distance-to-agreement of 3 mm, which was anticipated due to the simulated errors in afterloader delivery. Performing the dose calculations and using the 2D gamma analysis to compare the dose profiles allowed for additional verification of the treatment delivery, which could also be used to verify the dose calculations of the treatment planning system.
Conclusion
The novel "magic phantom" system and software has demonstrated its ability to verify treatment In future work, the "magic phantom" will be used to verify real patient plans and will translate measured dwell positions and time patterns to 3D dose calculations, including contributions of dose associated with source transition. The comparison of planned 3D doses by TPS and calculated values will complement the innovative position-time gamma analysis and provide comprehensive QA of the entire treatment delivery.
